Log in

Anavex Life Sciences SEC Filings & 10K Form (NASDAQ:AVXL)

$5.09
-0.07 (-1.36 %)
(As of 02/24/2020 01:24 AM ET)
Today's Range
$4.91
Now: $5.09
$5.35
50-Day Range
$2.64
MA: $3.57
$5.81
52-Week Range
$2.10
Now: $5.09
$6.31
Volume1.41 million shs
Average Volume1.52 million shs
Market Capitalization$298.63 million
P/E RatioN/A
Dividend YieldN/A
Beta2.11

SEC Filings

Anavex Life Sciences (NASDAQ:AVXL) SEC Filings

DateFilerForm TypeView
02/07/2020
7:45 AM
Anavex Life Sciences (Subject)
BlackRock Inc. (Filed by)
Form SC 13G
01/08/2020
5:00 PM
Anavex Life Sciences (Issuer)
Boenisch Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2020
5:00 PM
Anavex Life Sciences (Issuer)
Velden Claus Vander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2020
5:00 PM
Anavex Life Sciences (Issuer)
Thomas Steffen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2020
5:00 PM
Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2020
5:00 PM
Anavex Life Sciences (Issuer)
FAVUS ELLIOT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2020
5:00 PM
Anavex Life Sciences (Issuer)
Donhauser Peter D.O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2020
5:00 PM
Anavex Life Sciences (Issuer)
Skarpelos Athanasios (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2019
4:16 PM
Anavex Life Sciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
09/22/2019
11:15 PM
Anavex Life Sciences (Filer)
Form EFFECT
09/17/2019
4:15 PM
Anavex Life Sciences (Filer)
Form POS AM
09/16/2019
3:16 PM
Anavex Life Sciences (Filer)
Form AW
09/13/2019
4:10 PM
Anavex Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2019
4:06 PM
Anavex Life Sciences (Filer)
Form 424B5
09/13/2019
4:01 PM
Anavex Life Sciences (Filer)
Form S-3/A
07/15/2019
11:16 PM
Anavex Life Sciences (Filer)
Form EFFECT
07/03/2019
3:31 PM
Anavex Life Sciences (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/12/2019
4:01 PM
Anavex Life Sciences (Filer)
Form 424B5
06/12/2019
3:58 PM
Anavex Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2019
6:27 PM
Anavex Life Sciences (Issuer)
Boenisch Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2019
3:31 PM
Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2019
3:39 PM
Anavex Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2019
5:26 AM
Anavex Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2019
8:14 PM
Anavex Life Sciences (Filer)
Form 424B5
02/14/2019
3:52 PM
Anavex Life Sciences (Subject)
Park West Asset Management LLC (Filed by)
Form SC 13G/A
02/11/2019
3:10 PM
Anavex Life Sciences (Filer)
Form DEF 14A
02/07/2019
3:31 PM
Anavex Life Sciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
01/31/2019
3:31 PM
Anavex Life Sciences (Filer)
Form PRE 14A
01/25/2019
4:06 PM
Anavex Life Sciences (Filer)
Form 10-K/A
12/12/2018
3:39 PM
Anavex Life Sciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
10/09/2018
3:42 PM
Anavex Life Sciences (Issuer)
Skarpelos Athanasios (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2018
4:33 PM
Anavex Life Sciences (Issuer)
FAVUS ELLIOT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2018
4:32 PM
Anavex Life Sciences (Issuer)
Velden Claus Vander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2018
4:31 PM
Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2018
4:30 PM
Anavex Life Sciences (Issuer)
Thomas Steffen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2018
4:29 PM
Anavex Life Sciences (Issuer)
Boenisch Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2018
4:27 PM
Anavex Life Sciences (Issuer)
Donhauser Peter D.O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2018
4:06 PM
Anavex Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/06/2018
4:03 PM
Anavex Life Sciences (Filer)
Form 424B5
05/17/2018
4:23 PM
Anavex Life Sciences (Issuer)
Boenisch Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2018
4:16 PM
Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2018
11:35 AM
Anavex Life Sciences (Issuer)
Velden Claus Vander (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/20/2018
3:31 PM
Anavex Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/09/2018
2:16 PM
Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2018
4:00 PM
Anavex Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2018
10:01 AM
Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2018
1:06 PM
Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2018
7:56 AM
Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2018
3:57 PM
Anavex Life Sciences (Subject)
Park West Asset Management LLC (Filed by)
Form SC 13G/A
12/15/2017
3:11 PM
Anavex Life Sciences (Issuer)
Boenisch Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2017
3:09 PM
Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2017
4:14 PM
Anavex Life Sciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
This page was last updated on 2/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel